Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO.
Information is presented on legal manufacture, distribution, medical uses and in various countries of the stimulants and hallucinogens under consideration by the World Health Organization (WHO). Data are reported from the Substance Abuse Warning System (SAWS) in the F.R.G. and other surveillance systems regarding illicit manufacture, trafficking and abuse of these compounds internationally. In addition, it is pointed out that assessment of the liability of these compounds for abuse must consider not only the substance itself but also its potential metabolic products. These data, collectively, indicate that the substances currently of most concern with respect to abuse are fenetylline and norpseudoephedrine.
D000662:Amphetamines; D000983:Antipyrine / Q000031:analogs & derivatives; D000697:Central Nervous System Stimulants; D004053:Diethylpropion; D006213:Hallucinogens; D006801:Humans; D010665:Phenylpropanolamine; D011437:Propylamines; D019966:Substance-Related Disorders / Q000453:epidemiology*; D013806:Theophylline / Q000031:analogs & derivatives; D014944:World Health Organization
D000662:Amphetamines; D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D011437:Propylamines; C005331:norpseudoephedrine; D010665:Phenylpropanolamine; C009385:morazone; D013806:Theophylline; D004053:Diethylpropion; D000983:Antipyrine; C004518:fenethylline